Financial Services
Regent Pacific Group Limited(RPGLF)
Live Price
Offline$0.0059
+0.00% today
1Y Change
+742.86%
Window
Jun 20, 2025 โ Jun 12, 2026
- Market Cap
- $20.00M
- Revenue Growth
- -51.5%
- EPS Growth
- +8.2%
- Dividend Yield
- 0.0%
Coverage: 247 bars ยท Jun 20, 2025 โ Jun 12, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Regent Pacific Group Limited (RPGLF) is a Financial Services stock with a market cap of $20.00M and listed on OTC. The stock last traded around $0.01 and up 742.9% across the available one-year price window (Jun 20, 2025 โ Jun 12, 2026). Baseline metrics include revenue growth of -51.5%, EPS growth of +8.2%, a dividend yield of 0.0%. What stands out right now is revenue -51.5%, EPS +8.2%, free cash flow 0.0% with operating margin -1251.1% and ROIC -754.3%. Valuation already assumes a fairly strong business story at price/sales 67.1. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines RPGLF price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Financial Services peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Below sector median
-51.5% vs +3.4% peer median
Operating Margin
Below sector median
-1251.1% vs +4.7% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2025 was reported on Mar 27, 2025, but the surprise data is still limited.
The operating picture looks softer than before
Revenue is at -51.5% and EPS is at +8.2%, with operating margin around -1251.1%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2025 Mar 27, 2025 | โ | +0.0% | +0.0% | +0.0% |
2024 Aug 28, 2024 | โ | +0.0% | +0.0% | +0.0% |
2024 May 30, 2024 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RPGLF
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RPGLF Max Drawdown
-98.64%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RPGLF and SPY.
Company Overview
Regent Pacific Group Limited
Other OTC
Regent Pacific Group Limited, an investment holding company, holds investments in the healthcare and life sciences sectors in Europe and Taiwan. The company operates in two segments, Biopharma and Corporate Investment. It engages in the research, development, manufacture, marketing, and sale of pharmaceutical products for the treatment and management of urological disorders; and development of artificial intelligence systems to track the rate of aging at the molecular, cellular, tissue, organ, system, physiological, and psychological levels. The company also invests in listed and unlisted corporate entities. In addition, it provides management services.
- Leadership
- Jamie Alexander Gibson
- IPO Date
- May 22, 1997
- Employees
- 13
- Street Address
- Henley Building
- Mailing
- Central
- Region
- Central, HK
- Reporting Currency
- USD
- Investor Line
- 852 2514 6111
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- โ
- Price/Sales
- 67.1
- Price/Book
- โ
Growth
- Revenue
- -51.5%
- EPS
- +8.2%
- Free Cash Flow
- 0.0%
Profitability
- Gross Margin
- -12.1%
- Operating Margin
- -1251.1%
- Net Margin
- -1369.8%
- ROE
- 87.2%
- ROIC
- -754.3%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.07
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.